Table 2 Comparison of NYHA, EF, blood pressure, treatment, and laboratory findings between patients with and without AKI
Parameter | Non-AKI (n = 30) | AKI (n = 30) | P value |
|---|---|---|---|
NYHA class D1 | |||
1 | 0 (0.0%) | 0 (0.0%) | 0.046 |
2 | 0 (0.0%) | 1 (3.3%) | |
3 | 12 (40.0%) | 4 (13.3%) | |
4 | 18 (60.0%) | 25 (83.3%) | |
NYHA class D2 | |||
1 | 1 (3.3%) | 2 (6.7%) | 0.014 |
2 | 15 (50.0%) | 6 (20.0%) | |
3 | 13 (43.3%) | 13 (43.3%) | |
4 | 1 (3.3%) | 9 (30.0%) | |
NYHA class D3 | |||
1 | 6 (20.0%) | 5 (16.7%) | 0.017 |
2 | 21 (70.0%) | 12 (40.0%) | |
3 | 3 (10.0%) | 7 (23.3%) | |
4 | 0 (0.0%) | 6 (20.0%) | |
SBP* | 110.0 (60–210) | 100.0 (60–200) | 0.026 |
DBP* | 70.0 (30–110) | 60.0 (40–100) | 0.032 |
EF* | 40.0 (18–55) | 38.5 (19–55) | 0.486 |
Length of stay in hospital* | 4.5 (3–18) | 8.5 (3–29) | < 0.001 |
Treatment | |||
ACEIS | 27 (90.0%) | 9 (30.0%) | < 0.001 |
BB | 24 (80.0%) | 16 (53.3%) | 0.028 |
MRA | 26 (86.7%) | 10 (33.3%) | < 0.001 |
Diuretics | 30 (100.0%) | 29 (96.7%) | 1.00 |
Inotropics | 8 (26.7%) | 12 (40.0%) | 0.273 |
Vasopressors | 1 (3.3%) | 12 (40.0%) | 0.001 |
HCT* | 35.5 ± 5.7 | 34.1 ± 6.3 | 0.373 |
Creatinine (first reading) | 1.3 (0.7–2.9) | 2.5 (0.7–5.9) | < 0.001 |
Creatinine (second reading) | 1.3 (1.0–3.0) | 3.0 (2.0–6.0) | < 0.001 |
Creatinine (third reading) | 1.1 (0.8–1.9) | 2.8 (0.9–5.8) | < 0.001 |
Urea (first reading) | 43.5 (22–88) | 98.0 (31–210) | < 0.001 |
Urea (second reading) | 46.5 (28–157) | 136.5 (20–280) | < 0.001 |
Urea (third reading) | 38.0 (21–95) | 100.0 (30–290) | < 0.001 |
BUN (first reading) | 21.0 (10.2–65.4) | 45.7 (14.4–98.0) | < 0.001 |
BUN (second reading) | 21.5 (13–73) | 63.5 (19–130) | < 0.001 |
BUN (third reading) | 17.4 (10.5–44.3) | 46.0 (14–135.5) | < 0.001 |
BUN/Cr (first reading) | 15.4 (10.5–41.4) | 21.1 (7.7–37.0) | 0.013 |
BUN/Cr (second reading) | 15.0 (10–27) | 17.0 (8.0–37) | 0.048 |
BUN/Cr (third reading) | 14.9 (11.6–26.2) | 19.5 (4.7–32.3) | 0.046 |
GFR (first reading) | 76.8 (28.1–144) | 34.4 (14.1–167.0) | < 0.001 |
GFR (second reading) | 66.0 (24–123) | 30.0 (12–73) | < 0.001 |
GFR (third reading) | 83.0 (36–115) | 30.5 (10.1–110.2) | < 0.001 |
Albumin | 3.9 (3.0–4.8) | 3.8 (1.2–4.5) | 0.047 |
INR | 1.0 (1.0–2.0) | 1.0 (1.0–3.0) | 0.113 |
Na | 124.0 (120–128) | 123.5 (120–128) | 0.759 |
K | 4.0 (2.9–6.0) | 5.0 (3.0–6.0) | 0.016 |